(VIANEWS) – Sunoco LP (SUN), Robert Half International (RHI), Organogenesis Holdings (ORGO) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Sunoco LP (SUN)

31.7% sales growth and 70.66% return on equity

Sunoco LP, together with its subsidiaries, distributes and retails motor fuels in the United States.

Sunoco LP’s sales growth this year is expected to be 60.2% and 9.5% for next year.

Year-on-year quarterly revenue growth grew by 70.4%, now sitting on 15.19B for the twelve trailing months.

Volume

Today’s last reported volume for Sunoco LP is 234789 which is 22.66% below its average volume of 303614.

Sunoco LP’s sales growth for the next quarter is 31.7%. The company’s growth estimates for the ongoing quarter and the next is 45.5% and negative -40%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 70.66%.

Volatility

Sunoco LP’s last day, last week, and last month’s current intraday variation average was 4.75%, 2.00%, and 1.34%, respectively.

Sunoco LP’s highest amplitude of average volatility was 3.79% (day), 2.55% (last week), and 2.46% (last month), respectively.

Sunoco LP’s Stock Yearly Top and Bottom Value

Sunoco LP’s stock is valued at $43.84 at 05:22 EST, below its 52-week high of $46.95 and way above its 52-week low of $30.01.

Sunoco LP’s Moving Average

Sunoco LP’s value is above its 50-day moving average of $41.14 and way higher than its 200-day moving average of $38.54.

2. Robert Half International (RHI)

21.7% sales growth and 47.48% return on equity

Robert Half International Inc. provides staffing and risk consulting services in North America, South America, Europe, Asia, and Australia.

Robert Half International’s sales growth this year is anticipated to be 13% and 5.7% for next year.

Year-on-year quarterly revenue growth grew by 35.7%, now sitting on 6.46B for the twelve trailing months.

Volume

Today’s last reported volume for Robert Half International is 1150630 which is 25.98% above its average volume of 913293.

Robert Half International’s sales growth for the next quarter is 21.7%. The company’s growth estimates for the current quarter and the next is 48% and 13.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 47.48%.

Volatility

Robert Half International’s last day, last week, and last month’s current intraday variation average was 0.76%, 1.36%, and 1.16%, respectively.

Robert Half International’s highest amplitude of average volatility was 2.15% (day), 2.63% (last week), and 2.93% (last month), respectively.

Robert Half International’s Stock Yearly Top and Bottom Value

Robert Half International’s stock is valued at $119.26 at 05:22 EST, under its 52-week high of $120.83 and way higher than its 52-week low of $71.03.

Robert Half International’s Moving Average

Robert Half International’s value is above its 50-day moving average of $110.86 and way higher than its 200-day moving average of $101.76.

3. Organogenesis Holdings (ORGO)

19.7% sales growth and 48.88% return on equity

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States.

Organogenesis Holdings ‘s sales growth this year is expected to be 37.1% and 9.6% for next year.

Year-on-year quarterly revenue growth grew by 12.9%, now sitting on 446.31M for the twelve trailing months.

Volume

Today’s last reported volume for Organogenesis Holdings is 1030000 which is 17.88% above its average volume of 873701.

Organogenesis Holdings ‘s sales growth for the next quarter is 19.7%. The company’s growth estimates for the ongoing quarter and the next is a negative 46.7% and 14.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.88%.

Volatility

Organogenesis Holdings ‘s last day, last week, and last month’s current intraday variation average was 5.87%, 6.38%, and 4.01%, respectively.

Organogenesis Holdings ‘s highest amplitude of average volatility was 8.57% (day), 7.92% (last week), and 6.74% (last month), respectively.

Organogenesis Holdings ‘s Stock Yearly Top and Bottom Value

Organogenesis Holdings ‘s stock is valued at $6.47 at 05:22 EST, way below its 52-week high of $24.34 and higher than its 52-week low of $6.42.

Organogenesis Holdings ‘s Moving Average

Organogenesis Holdings ‘s worth is way under its 50-day moving average of $8.39 and way below its 200-day moving average of $12.96.

4. Columbus McKinnon Corporation (CMCO)

10.1% sales growth and 4.41% return on equity

Columbus McKinnon Corporation designs, manufactures, and markets intelligent motion solutions to ergonomically move, lift, position, and secure materials worldwide.

Columbus McKinnon Corporation’s sales growth this year is anticipated to be 36.8% and 10% for next year.

Year-on-year quarterly revenue growth grew by 29.7%, now sitting on 839.42M for the twelve trailing months.

Volume

Today’s last reported volume for Columbus McKinnon Corporation is 107536 which is 7.14% above its average volume of 100366.

Columbus McKinnon Corporation’s sales growth for the next quarter is 10.1%. The company’s growth estimates for the current quarter and the next is 56% and 17.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.41%.

Volatility

Columbus McKinnon Corporation’s last day, last week, and last month’s current intraday variation average was 1.10%, 1.49%, and 1.38%, respectively.

Columbus McKinnon Corporation’s highest amplitude of average volatility was 2.37% (day), 3.74% (last week), and 4.18% (last month), respectively.

Columbus McKinnon Corporation’s Stock Yearly Top and Bottom Value

Columbus McKinnon Corporation’s stock is valued at $44.44 at 05:22 EST, way under its 52-week high of $57.06 and higher than its 52-week low of $41.01.

Columbus McKinnon Corporation’s Moving Average

Columbus McKinnon Corporation’s value is below its 50-day moving average of $45.89 and under its 200-day moving average of $47.55.

LEAVE A REPLY

Please enter your comment!
Please enter your name here